{"id":"https://openalex.org/W2115015071","doi":"https://doi.org/10.1016/s0140-6736(89)91549-3","title":"INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA","display_name":"INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA","alternate_titles":[],"publication_year":1989,"publication_date":"1989-10-01","ids":{"openalex":"https://openalex.org/W2115015071","doi":"https://doi.org/10.1016/s0140-6736(89)91549-3","mag":"2115015071","pmid":"https://pubmed.ncbi.nlm.nih.gov/2571813"},"language":"en","primary_location":{"id":"doi:10.1016/s0140-6736(89)91549-3","doi":"https://doi.org/10.1016/s0140-6736(89)91549-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(89)91549-3","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2115015071"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108358409","display_name":"Diana Samson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802369498","display_name":"Charing Cross Hospital","ror":"https://ror.org/02gcp3110","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2802369498"]},{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Diana Samson","raw_affiliation_strings":["Department of Haematology, Charing Cross and Westminster Medical School, London","Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Charing Cross and Westminster Medical School, London","institution_ids":["https://openalex.org/I2802369498","https://openalex.org/I45129253"]},{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011059993","display_name":"Adrian C. Newland","orcid":"https://orcid.org/0000-0003-1079-9496","observed_orcids":["https://orcid.org/0000-0003-1079-9496"]},"institutions":[{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adrian Newland","raw_affiliation_strings":["London Hospital, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"London Hospital, United Kingdom","institution_ids":["https://openalex.org/I2801259928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074108684","display_name":"Joseph Kearney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joseph Kearney","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052409809","display_name":"M V Joyner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Miles Joyner","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Terry Mitchell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Terry Mitchell","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105342113","display_name":"A.John Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A.John Barrett","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111392517","display_name":"Elizabeth Gaminara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth Gaminara","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053153884","display_name":"J. E. W. Van de Pette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Van De Pette","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111547166","display_name":"Donald M. McCarthy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Donald McCarthy","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073615639","display_name":"Lyn Aston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lyn Aston","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018258179","display_name":"M. D. Hamon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mike Hamon","raw_affiliation_strings":["London Hospital, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"London Hospital, United Kingdom","institution_ids":["https://openalex.org/I2801259928"]}]},{"author_position":"last","author":{"id":null,"display_name":"Maggie Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166787","display_name":"Riverside","ror":"https://ror.org/05y0cez87","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210166787"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maggie Evans","raw_affiliation_strings":["Riverside Haematology Group, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Riverside Haematology Group, United Kingdom","institution_ids":["https://openalex.org/I4210166787"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":7890,"currency":"USD","value_usd":7890},"apc_paid":null,"fwci":3.7824,"has_fulltext":false,"cited_by_count":193,"citation_normalized_percentile":{"value":0.93442762,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"334","issue":"8668","first_page":"882","last_page":"885"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/vad-chemotherapy","display_name":"VAD chemotherapy","score":0.6869999766349792},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9129999876022339},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8330000042915344},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8209999799728394},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.6100000143051147},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.8100000023841858},{"id":"https://openalex.org/keywords/corticosteroid-side-effects","display_name":"corticosteroid adverse effects","score":0.7860000133514404},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8334168791770935},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.8218660354614258},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.8150322437286377},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7342529892921448},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6076799631118774},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5628427863121033},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.5274774432182312},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4776157736778259},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4690176844596863},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46621567010879517},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.46057936549186707},{"id":"https://openalex.org/C2776581026","wikidata":"https://www.wikidata.org/wiki/Q864868","display_name":"Bone marrow suppression","level":3,"score":0.45485571026802063},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.375274658203125},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35548579692840576},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.255361407995224}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0140-6736(89)91549-3","doi":"https://doi.org/10.1016/s0140-6736(89)91549-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(89)91549-3","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},{"id":"pmid:2571813","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2571813","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet (London, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1964073968","https://openalex.org/W1972264308","https://openalex.org/W2004136640","https://openalex.org/W2006382315","https://openalex.org/W2024399304","https://openalex.org/W2026295989","https://openalex.org/W2038252730","https://openalex.org/W2075607397","https://openalex.org/W2084091547","https://openalex.org/W2099704297","https://openalex.org/W2219691369","https://openalex.org/W2427257480"],"related_works":["https://openalex.org/W2022248147","https://openalex.org/W2013475630","https://openalex.org/W2121715057","https://openalex.org/W1991731889","https://openalex.org/W2273869333","https://openalex.org/W2022413505","https://openalex.org/W2158040196","https://openalex.org/W1999272035","https://openalex.org/W1974988990"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2115015071","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
